GlassScriptPhysician profile
Pierre Tamer
NPI 1962965285
$3,581.25
in general payments reported to CMS, 2019-2025
8 companies · $1,952 in 2025
The $1,952 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $341 · 2023: $176 · 2024: $1,112 · 2025: $1,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,196 · Travel and Lodging: $1,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,195.58 |
| Travel and Lodging | $1,044.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,662.52 | 2022-2025 | Mako, Aequalis Flex Revive, Blueprint Patient Specific Instrumentation |
| Medical Device Business Services, INC. | $318.38 | 2024-2025 | Attune, Velys |
| Encore Medical, LP | $258.66 | 2025 | |
| Depuy Synthes Sales INC. | $248.82 | 2024 | Na, Motoband |
| Moximed, INC | $35.45 | 2025 | Misha Knee System, Small, Left |
| Orthofix Medical, INC. | $20.83 | 2023 | Galaxy Fixation System, Galaxy Fixation Gemini, Truelok |
| Si-Bone, INC. | $19.07 | 2024 | |
| Sanara Medtech INC. | $17.52 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Tamer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.